Clinical trial
Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells
NCT00630721 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells
- Lead sponsor
- University of North Carolina, Chapel Hill
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2007
- Completion date
- March 15, 2011
- Enrollment
- 56 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.